A clinical trial to test the safety of treating heart attack damage with stem cells is about to get under way, following a study that showed the therapy helped in pigs. Two patients have been enrolled so far at Johns Hopkins Hospital in Baltimore, and a total of 48 are expected to take part across the country, said Dr Joshua M. Hare, who is leading the study.